Patient Resources / HIPEC vs PIPAC
Two specialist treatments for cancer that has spread to the lining of the abdomen (peritoneal cancer). This guide explains how they differ, who may be considered for each, and what to discuss with your treating team.


| Feature | HIPEC | PIPAC |
|---|---|---|
| Full name | Hyperthermic Intraperitoneal Chemotherapy | Pressurised Intraperitoneal Aerosol Chemotherapy |
| How the drug is given | Heated chemotherapy, about 41 to 43 °C (106 to 109 °F), delivered into the abdomen | Chemotherapy as a pressurised aerosol at normal body temperature |
| Surgery | Major open cytoreductive surgery | Keyhole (laparoscopic) surgery |
| Number of sessions | Usually a single session | Repeatable, often every 4 to 6 weeks |
| Typical use | Limited disease that can be completely removed | Extensive disease, or patients not suited to major surgery |
| Typical hospital stay | About 10 to 21 days | About 1 to 3 days |
Candidacy is always individual. Imaging and, where needed, diagnostic laparoscopy show how far the disease has spread.
CRS-HIPEC is a major undertaking, suited to carefully selected patients. PIPAC is a less invasive, repeatable option for a different group of patients. PIPAC is a newer treatment, much of its evidence comes from small studies, and many of its uses are still being studied. Results and practice can vary between hospitals, so ask your team about their experience.
Is PIPAC an alternative to HIPEC?
Not in a simple sense. The two generally serve different patients. HIPEC is for limited disease that can be completely removed by surgery, and PIPAC is for more extensive disease or for patients not suited to major surgery. Which one applies, if either, is decided after evaluation.
Which procedure is more invasive?
HIPEC involves major open surgery. PIPAC is performed laparoscopically (keyhole) and is described as minimally invasive.
How many treatments are needed?
HIPEC is usually a single session. PIPAC is repeatable, often every 4 to 6 weeks.
Which cancers are treated?
Both are used for peritoneal spread from ovarian, colorectal, appendiceal and gastric cancers. HIPEC is also used for peritoneal mesothelioma.
Who makes the decision?
A multidisciplinary tumour board reviews each patient before a decision is made.
If you are deciding between these options, you can request an expert opinion before any treatment decision. The information on this page is general and does not replace an evaluation by your treating team.
Dr Ashwin K.R., Senior Consultant, Aster Whitefield, Bangalore.
Medically reviewed by Dr Ashwin K.R. on 10 October 2026.